SCHEMBL14228049

SCHEMBL14228049

OC[C@H]1C[C@@H](O)CN1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12164678 1.00 — —
SCHEMBL14535578 0.74 — —
SCHEMBL13899690 0.71 — —
SCHEMBL11993838 0.71 — —
SCHEMBL8313622 0.71 — —
SCHEMBL9664556 0.71 — —
SCHEMBL8320331 0.71 — —
SCHEMBL5321769 0.71 — —
SCHEMBL8315049 0.71 — —
SCHEMBL10225746 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080085886-A1 Anticancer and/or antiinflammatory activity, MEK (MAP kinase kinase) inhibitors; for example, 3-(2-Fluoro-4-iodo-phenylamino)-furo[3,2-c]pyridine-2-carboxylic acid ((R)-2,3-dihydroxy-propoxy)-amide GENENTECH, INC. 2008-04-10 — — US disclosed
Send feedback